The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation

Table 3 Lifetime incidence of diabetes-related complications and depression episodes

Results per 2,000,000 people	Current practice (CP)	Policy 1^a	Policy 2^b	Policy 3^c	Policy 1 — CP	Policy 2 — CP	Policy 3 — CP
Number of microvascular complications
Blindness	116,237	114,360	115,070	113,287	−1,877	−1,167	−2,950
Renal failure	68,633	66,840	66,890	66,150	−1,793	−1,743	−2,483
Diabetic ulcer	69,320	68,803	68,633	67,920	−517	−687	−1,400
Amputation	87,017	85,303	85,450	84,560	−1,713	−1,567	−2,457
Total	341,207	335,306	336,043	331,917	−5,900	−5,164	−9,290
Number of macrovascular complications
IHD	277,880	275,627	276,923	274,883	−2,253	−957	−2,997
MI	377,417	374,227	374,190	373,437	−3,190	−3,227	−3,980
Stroke	274,880	273,010	272,980	271,650	−1,870	−1,900	−3,230
CHF	221,130	219,640	219,250	218,587	−1,490	−1,880	−2,543
Total	1,151,307	1,142,504	1,143,343	1,138,557	−8,803	−7,964	−12,750
Number depression episodes (1,000)
Total number	15,517	15,598	15,563	15,605	80	46	88
Identified	7,937	7,983	13,547	13,588	46	5,610	5,650
Unidentified	7,580	7,615	2,016	2,018	35	−5,564	−5,562

CP Current practice, IHD Ischaemic heart disease, MI Myocardial infarction, CHF Congestive heart failure. ^aPolicy 1 = collaborative care; ^bPolicy 2 = opportunistic screening; ^cPolicy 3 = both collaborative care and opportunistic screening

ISSN: 1472-6963